Imaging News and Research

RSS

U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound system

U-Systems, the leader in automated breast ultrasound, launched a revolutionary new transducer technology designed to deliver unparalleled imaging performance and patient comfort. Reverse-Curve Crystal™ (RCC) Transducer Technology was designed and optimized for use with the U-Systems' somo•v® Automated Breast Ultrasound (ABUS) system.

18 May 2011

Clinical PET system for early stage breast cancer diagnosis

European researchers have developed a clinical PET system with the highest resolution and sensitivity in the market, specifically dedicated to breast cancer detection in early stages.

18 May 2011

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the first quarter ended March 31, 2011.

18 May 2011

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today commented on new diagnostic criteria and guidelines for Alzheimer’s disease published recently by the National Institute on Aging (NIA) and the Alzheimer’s Association, which have been updated for the first time in more than 25 years. The new guidelines discuss the importance of new technologies, including brain imaging and biomarker analysis, in research and clinical diagnosis. They describe Alzheimer’s disease at a preclinical stage, Mild Cognitive Impairment (MCI) due to Alzheimer’s disease, and dementia due to Alzheimer’s pathology.

18 May 2011

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

A global leader in advancing the treatment of cardiovascular disease through innovative medical technology, Medtronic, Inc. today announced recent milestones in its clinical program for the IN.PACT drug-eluting balloon technology.

From Medtronic 17 May 2011

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Published in the April issue of Journal of Nuclear Medicine, Gamma Medica, Inc. and Mayo Clinic of Rochester, MN document the achievement of a 5-fold reduction in the necessary dose of Tc-99m sestamibi to perform Molecular Breast Imaging (MBI). This achievement enables the new LumaGEM™ MBI System by Gamma Medica to deliver the same low radiation dose as digital screening mammography.

17 May 2011

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced data from a Phase 2 clinical trial that demonstrated Positron Emission Tomography myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography myocardial perfusion imaging, the current standard for the non-invasive detection of CAD.

17 May 2011

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

Although so-called clot-busting drugs are commonly used in the treatment of some patients with blood clots in the lungs, a new study conducted by researchers in Spain and the U.S. indicates the agents do not appear to be any more effective than traditional blood thinners for the majority of these patients.

17 May 2011

'Mu opioid' receptors in the brain linked to smoking relapse

Nearly everyone who has tried to quit smoking says it's incredibly difficult, and the struggle is due in part to genetic factors. Now, a new study from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania sheds light on how one specific genetic risk for smoking relapse may work: Some of the difficulties may be due to how many receptors, called "mu opioid" receptors, a smoker has in his or her brain.

17 May 2011

Super-resolution microscopy technique reveals how and why cell's defenses fail against plague

Researchers at Sandia National Laboratories have developed a super-resolution microscopy technique that is answering long-held questions about exactly how and why a cell's defenses fail against some invaders, such as plague, while successfully fending off others like E.coli.

17 May 2011

City of Philadelphia chooses eClinicalWorks' EHR suite to help improve patient care

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that the City of Philadelphia has selected the company to help improve the continuity of care for the City's Department of Public Health.

16 May 2011

IOD completes acquisition of Confidential Copiers

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced the completion of a strategic acquisition of Confidential Copiers Inc.

16 May 2011

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

Volcano Corporation today announced its participation in the Paris course for Revascularization from May 17 – 20. Volcano's focus will be on highlighting the strength of its product portfolio, which includes innovative devices like the Vascular Imaging Balloon Catheter, and its sponsorship of a symposium that highlights the use and value of Precision Guided Therapy in clinical practice today.

16 May 2011

Bedside screening tool can help diagnose acute aortic dissection

The most lethal and sudden cardiovascular event can be the toughest for doctors to diagnose. But a study by the University of Michigan Cardiovascular Center shows new guidelines are effective for determining who's most likely suffering from an aortic dissection, which is tearing in the lining of the body's largest blood vessel.

16 May 2011

Roche initiates TB-403 Phase Ib/II study in glioblastoma multiforme

ThromboGenics and co-development partner BioInvent International announce today that their partner Roche has dosed the first patient in a Phase Ib/II study with the novel antibody anti-cancer agent TB-403 (RG7334).

16 May 2011

New ACR Dose Index Registry allows imaging community to measure effectiveness of dose lowering efforts

Medical imaging facilities can now submit anonymized dose information for all CT exams performed to the Dose Index Registry (DIR) — allowing them to compare their dose indices to other facilities of similar size or geographic area and to national benchmarks. Participating facilities receive periodic feedback comparing their dose levels to these benchmarks, enabling them to make any necessary adjustments to lower dose received from scans.

13 May 2011

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.

From Quest Diagnostics 13 May 2011

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

Dr. Lawrence W. Bassett, a nationally renowned expert with more than 35 years experience in breast imaging, has been chosen to receive the Gold Medal by the American College of Radiology, the organization's highest honor given for distinguished and extraordinary service in the field of radiology.

13 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

Medtronic to present new clinical results on innovative medical devices at EuroPCR

New clinical data on a range of innovative medical devices from Medtronic, Inc., to treat cardiac and vascular diseases - from severe aortic stenosis and uncontrolled hypertension, to coronary and peripheral artery disease - will be presented next week at EuroPCR. Many of the presentations will be featured during late-breaking sessions at this large international interventional cardiology meeting, which takes place in Paris from May 17-20.

From Medtronic 12 May 2011

Imaging News and Research

U-Systems introduces RCC Transducer Technology for somo•v Automated Breast Ultrasound system

Clinical PET system for early stage breast cancer diagnosis

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Anavex comments on new Alzheimer’s disease diagnostic guidelines

Medtronic to present clinical trial data of IN.PACT drug-eluting balloon technology at EuroPCR meeting

Study achieves 5-fold reduction in Tc-99m sestamibi dosage for molecular breast imaging

Phase 2 trial data of PET myocardial perfusion imaging with flurpiridaz F 18 presented at ICNC10

Thrombolytic therapy linked to poor survival in pulmonary embolism patients with normal blood pressure

'Mu opioid' receptors in the brain linked to smoking relapse

Super-resolution microscopy technique reveals how and why cell's defenses fail against plague

City of Philadelphia chooses eClinicalWorks' EHR suite to help improve patient care

IOD completes acquisition of Confidential Copiers

Volcano to share intravascular therapy guidance and optimization solutions at EuroPCR

Bedside screening tool can help diagnose acute aortic dissection

Roche initiates TB-403 Phase Ib/II study in glioblastoma multiforme

New ACR Dose Index Registry allows imaging community to measure effectiveness of dose lowering efforts

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Medtronic to present new clinical results on innovative medical devices at EuroPCR

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News